Literature DB >> 18224734

Mesenchymal stem cell tissue engineering: techniques for isolation, expansion and application.

Ippokratis Pountos1, Diane Corscadden, Paul Emery, Peter V Giannoudis.   

Abstract

Mesenchymal stem cells (MSCs) are undifferentiated multipotent cells which reside in various human tissues and have the potential to differentiate into osteoblasts, chondrocytes, adipocytes, fibroblasts and other tissues of mesenchymal origin. In the human body they could be regarded as readily available reservoirs of reparative cells capable to mobilize, proliferate and differentiate to the appropriate cell type in response to certain signals. These properties have triggered a variety of MSC-based therapies for pathologies including nonunions, osteogenesis imperfecta, cartilage damage and myocardial infarction. The outcome of these approaches is influenced by the methodologies and materials used during the cycle from the isolation of MSCs to their re-implantation. This review article focuses on the pathways that are followed from the isolation of MSCs, expansion and implantation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18224734     DOI: 10.1016/s0020-1383(08)70006-8

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  46 in total

1.  Surface antigenic profiling of stem cells from human omentum fat in comparison with subcutaneous fat and bone marrow.

Authors:  M Dhanasekaran; S Indumathi; A Kanmani; R Poojitha; K M Revathy; J S Rajkumar; D Sudarsanam
Journal:  Cytotechnology       Date:  2012-02-01       Impact factor: 2.058

2.  Enhancement of nerve regeneration along a chitosan conduit combined with bone marrow mesenchymal stem cells.

Authors:  Lei Zheng; Hui-Fei Cui
Journal:  J Mater Sci Mater Med       Date:  2012-06-03       Impact factor: 3.896

3.  Uncultured marrow mononuclear cells delivered within fibrin glue hydrogels to porous scaffolds enhance bone regeneration within critical-sized rat cranial defects.

Authors:  James D Kretlow; Patrick P Spicer; John A Jansen; Charles A Vacanti; F Kurtis Kasper; Antonios G Mikos
Journal:  Tissue Eng Part A       Date:  2010-10-12       Impact factor: 3.845

4.  RNAi functionalized scaffold for scarless skin regeneration.

Authors:  Xing Liu; Lie Ma; Changyou Gao
Journal:  Organogenesis       Date:  2013-04-01       Impact factor: 2.500

5.  Markers Are Shared Between Adipogenic and Osteogenic Differentiated Mesenchymal Stem Cells.

Authors:  Melanie Köllmer; Jason S Buhrman; Yu Zhang; Richard A Gemeinhart
Journal:  J Dev Biol Tissue Eng       Date:  2013-05-01

6.  Paracrine effects of mesenchymal stem cells in cisplatin-induced renal injury require heme oxygenase-1.

Authors:  Abolfazl Zarjou; Junghyun Kim; Amie M Traylor; Paul W Sanders; József Balla; Anupam Agarwal; Lisa M Curtis
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-03

7.  Use of chitosan conduit combined with bone marrow mesenchymal stem cells for promoting peripheral nerve regeneration.

Authors:  Lei Zheng; Hui-Fei Cui
Journal:  J Mater Sci Mater Med       Date:  2010-01-26       Impact factor: 3.896

8.  Adipose-derived stem cell delivery into collagen gels using chitosan microspheres.

Authors:  Shanmugasundaram Natesan; David G Baer; Thomas J Walters; Mary Babu; Robert J Christy
Journal:  Tissue Eng Part A       Date:  2010-04       Impact factor: 3.845

9.  Mesenchymal stem cell characteristics of human anterior cruciate ligament outgrowth cells.

Authors:  Andre F Steinert; Manuela Kunz; Patrick Prager; Thomas Barthel; Franz Jakob; Ulrich Nöth; Martha M Murray; Christopher H Evans; Ryan M Porter
Journal:  Tissue Eng Part A       Date:  2011-03-08       Impact factor: 3.845

10.  Embryonic stem cell marker expression pattern in human mesenchymal stem cells derived from bone marrow, adipose tissue, heart and dermis.

Authors:  Una Riekstina; Inese Cakstina; Vadims Parfejevs; Martin Hoogduijn; Georgs Jankovskis; Indrikis Muiznieks; Ruta Muceniece; Janis Ancans
Journal:  Stem Cell Rev Rep       Date:  2009-12       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.